应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BME BME信托
休市中 10-02 16:00:00 EDT
43.34
-0.27
-0.62%
盘后
43.34
+0.00
0.00%
19:30 EDT
最高
43.98
最低
43.23
成交量
4.25万
今开
43.71
昨收
43.61
日振幅
1.72%
总市值
5.60亿
流通市值
5.60亿
总股本
1,292万
成交额
184.60万
换手率
0.33%
流通股本
1,292万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
安进股价盘前大涨逾4%,受第三期临床试验结果提振。
智通财经 · 09-22
安进股价盘前大涨逾4%,受第三期临床试验结果提振。
宁德时代与埃及BME达成技术合作
智通财经 · 09-16
宁德时代与埃及BME达成技术合作
阿斯利康股价盘后跌超2%,因其三期临床试验结果令人失望。
智通财经 · 09-12
阿斯利康股价盘后跌超2%,因其三期临床试验结果令人失望。
118款生物药专利悬崖将至,中国药企业迎战MNC最大专利悬崖
蓝鲸财经 · 09-10
118款生物药专利悬崖将至,中国药企业迎战MNC最大专利悬崖
美股异动丨诺华制药涨超7%,多发性硬化症口服药后期临床试验结果积极
格隆汇 · 09-01
美股异动丨诺华制药涨超7%,多发性硬化症口服药后期临床试验结果积极
国泰海通|医药:大药诞生之自免系列四:“专利悬崖”将至,MNC看好哪些下一代自免大药
国泰君安证券研究 · 08-16
国泰海通|医药:大药诞生之自免系列四:“专利悬崖”将至,MNC看好哪些下一代自免大药
阿斯利康拟与百时美施贵宝4000亿美元重组传闻背后:专利悬崖、产品短板倒逼,AZ端反对声大
蓝鲸财经 · 08-04
阿斯利康拟与百时美施贵宝4000亿美元重组传闻背后:专利悬崖、产品短板倒逼,AZ端反对声大
加载更多
公司概况
公司名称:
BME信托
所属市场:
NYSE
上市日期:
--
主营业务:
Blackrock Health Sciences Trust于2005年1月19日根据协议和信托声明组建为特拉华州法定信托,后来经过修订和重述,受特拉华州法律管辖,并于2005年3月31日开始运营。该基金根据1940年法案注册为多元化,封闭式管理投资公司。该基金的投资目标是通过当前收入,当前收益和长期资本增值的组合提供总回报。基金旨在通过主要投资于从事健康科学及相关行业的公司的股本证券以及与健康科学行业接触的股权衍生产品来实现这一目标。
发行价格:
--
{"stockData":{"symbol":"BME","market":"US","secType":"STK","nameCN":"BME信托","latestPrice":43.34,"timestamp":1790971200000,"preClose":43.61,"halted":0,"volume":42517,"hourTrading":{"tag":"盘后","latestPrice":43.34,"preClose":43.34,"latestTime":"19:30 EDT","volume":18,"amount":781.44,"timestamp":1790983807729,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006191240541160193,"floatShares":12924103,"shares":12924103,"eps":8.047614,"marketStatus":"休市中","change":-0.27,"latestTime":"10-02 16:00:00 EDT","open":43.71,"high":43.98,"low":43.23,"amount":1846016.881508,"amplitude":0.017198,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.047614,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":43.61,"aum":0,"dividendRate":0.072598,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":43.34,"preClose":43.34,"latestTime":"19:30 EDT","volume":18,"amount":781.44,"timestamp":1790983807729,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.282935625627924},"requestUrl":"/m/hq/s/BME","defaultTab":"news","newsList":[{"id":"2669114208","title":"安进股价盘前大涨逾4%,受第三期临床试验结果提振。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669114208?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:07","pubTimestamp":1790082475,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2242646821.SGD","MRNY","IDNA","BK4599","MEDI","PSCH","TMED","IEIH","BIB","BBH","FBT","BME","FTXH","BK4585","PBE","GNOM","LU2272731865.HKD","LFSC","PJP","SYNB","AMGN","CANC","RXL","HELX","IE00B5TLWC47.USD","IBRN","IEHS","PPH","TBXU","IBB","IE00B4R5TH58.HKD","LU2272731782.SGD","BIOY","IYH","BBP","IBBQ","LU2473716301.USD","AZNH","XPH","LU0122379950.USD","LU0320765992.SGD","SBIO","RSPH","XBIX","MRNX","LU1992135472.HKD","PBPH","WDNA","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667898600","title":"宁德时代与埃及BME达成技术合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2667898600","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667898600?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:08","pubTimestamp":1789556887,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BME","BK4585","BK4526","BK4519","BK4141","BK4588","JKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股价盘后跌超2%,因其三期临床试验结果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666571008?lang=zh_cn&edition=full","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2272731782.SGD","XPH","LU1992135472.HKD","LU2272731865.HKD","TMED","MEDI","BIB","LU2322448957.HKD","FTXH","LU2322448791.USD","BIOY","BME","BK4585","HELX","MRNX","BBP","PJP","WDNA","AZNH","IEIH","BBH","IE00B5TLWC47.USD","CANC","LFSC","PBPH","LU2272731600.USD","IBB","RXL","LU1992135399.USD","PPH","RSPH","LU2473716301.USD","IYH","XBIX","FBT","SBIO","BK4588","IBRN","IDNA","SYNB","IEHS","GNOM","PBE","MRNY","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666563124","title":"118款生物药专利悬崖将至,中国药企业迎战MNC最大专利悬崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2666563124","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666563124?lang=zh_cn&edition=full","pubTime":"2026-09-10 15:26","pubTimestamp":1789025185,"startTime":"0","endTime":"0","summary":"BCG合伙人杜菁博士指出,未来几年全球MNC将迎来史上最大专利悬崖,有118种生物制剂将会失去相应的专利保护,涉及2340亿美元市场。然而,目前这118款即将到期分子中,只有极少数在火热开发,大量缺口有待生物类似药填补。目前来说,创新药出海还没办法完成这个闭环,但生物类似药作为先头部队做出海试验,企业风险和获益会更高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789025064363150858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["MEDI","APXH","FXH","RSPH","TMED","IYH","PBPH","BBP","BBH","IHE","159839","BME","JDOC","PPH","TRUH","GSKH","FHLC","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664521258","title":"美股异动丨诺华制药涨超7%,多发性硬化症口服药后期临床试验结果积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2664521258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664521258?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:18","pubTimestamp":1788272338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0002141913.USD","IE00B4R5TH58.HKD","SBIO","IE00BFTCPJ56.SGD","IEIH","MRNX","IE00BJJMRZ35.SGD","XPH","MEDI","IE00BJT1NW94.SGD","BIB","LU0070302665.USD","IBRN","RSPH","WDNA","IDNA","BIOY","IE0009355771.USD","LU2322448957.HKD","LU2473716301.USD","LFSC","LU0211331839.USD","PSCH","PJP","AZNH","HELX","SYNB","LU2272731600.USD","FTXH","PBPH","TMED","MRNY","NVS","IBB","PPH","MEDX","BK4585","BK4007","XBIX","CANC","BK4588","BBP","FBT","IYH","GNOM","BBH","IEHS","BME","RXL","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660317064","title":"国泰海通|医药:大药诞生之自免系列四:“专利悬崖”将至,MNC看好哪些下一代自免大药","url":"https://stock-news.laohu8.com/highlight/detail?id=2660317064","media":"国泰君安证券研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660317064?lang=zh_cn&edition=full","pubTime":"2026-08-16 22:18","pubTimestamp":1786889880,"startTime":"0","endTime":"0","summary":"自免“专利悬崖”开启,MNC正积极布局下一代接棒管线仅考虑各家MNC核心自免资产,2026H1市场销售规模超700亿美元,同比增长近9%。报告名称:大药诞生之自免系列四:“专利悬崖”将至,MNC看好哪些下一代自免大药;报告日期:2026.08.14 报告作者:汪晋(分析师),登记编号:S0880526030004余克清(分析师),登记编号:S0880525120002余文心(分析师),登记编号:S0880525040111重要提醒本订阅号所载内容仅面向国泰海通证券研究服务签约客户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["research"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MzEwMDEzNQ==&mid=2650540470&idx=3&sn=7042e4acd674daff990a886cbfb65213&chksm=89513c50607e74835d610e4a7523db029bc5793640c09ee0ad94e7debc44c9117f4dc88efa10&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["601211","TMED","BK0028","159938","02611","BK0012","PJP","BK1574","PBPH","MEDI","BK0201","FHLC","BBH","APXH","RSPH","BK1564","09939","BK1147","PPH","BK0188","FXH","IHE","GSKH","BBP","JDOC","TRUH","BK1161","BME","BK0184","IYH","BK1515","BK0183","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656080539","title":"阿斯利康拟与百时美施贵宝4000亿美元重组传闻背后:专利悬崖、产品短板倒逼,AZ端反对声大","url":"https://stock-news.laohu8.com/highlight/detail?id=2656080539","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656080539?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:26","pubTimestamp":1785835565,"startTime":"0","endTime":"0","summary":"蓝鲸新闻记者联系了阿斯利康方面,对方拒绝对此置评。此外,BMS有神经管线与Eliquis后续心血管资产,可补足AZ在相关领域的短板。据BMO资本在研报中指出,两家公司都没有足够的财务实力直接收购对方,预计阿斯利康能掏出约370亿美元,而百时美施贵宝约为320亿美元,远低于搞定一桩价值4000亿美元合并所需的资金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785835141389493693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0868494617.USD","LU0225284248.USD","RSPH","LU2237443382.USD","IHE","LU1585245621.USD","BBH","FTXH","FXH","BBP","LU2462157665.USD","PPH","LU1670710588.SGD","JDOC","LU0321505868.SGD","TRUH","IE00B2B36J28.USD","LU0882574055.USD","LU2242646821.SGD","APXH","LU1868836914.USD","LU1093756325.SGD","IYH","AZN","LU2089984988.USD","BK4559","LU2237443895.HKD","LU0267386448.USD","LU0128525929.USD","PBPH","FHLC","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU0432979614.USD","LU1093756168.USD","BK4588","PJP","LU1670711123.USD","LU1032466523.USD","LU2596442595.SGD","MEDI","AZ","TMED","LU1868836591.USD","BMY","BME","AZNH","LU0985481810.HKD","GSKH","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blackrock.com","stockEarnings":[{"period":"1week","weight":-0.0335},{"period":"1month","weight":-0.0537},{"period":"3month","weight":-0.0071},{"period":"6month","weight":0.1173},{"period":"1year","weight":0.1539},{"period":"ytd","weight":0.0537}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Blackrock Health Sciences Trust于2005年1月19日根据协议和信托声明组建为特拉华州法定信托,后来经过修订和重述,受特拉华州法律管辖,并于2005年3月31日开始运营。该基金根据1940年法案注册为多元化,封闭式管理投资公司。该基金的投资目标是通过当前收入,当前收益和长期资本增值的组合提供总回报。基金旨在通过主要投资于从事健康科学及相关行业的公司的股本证券以及与健康科学行业接触的股权衍生产品来实现这一目标。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.011378},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.007715},{"month":3,"riseRate":0.47619,"avgChangeRate":-0.006181},{"month":4,"riseRate":0.636364,"avgChangeRate":0.004381},{"month":5,"riseRate":0.590909,"avgChangeRate":0.003882},{"month":6,"riseRate":0.590909,"avgChangeRate":0.006364},{"month":7,"riseRate":0.727273,"avgChangeRate":0.015713},{"month":8,"riseRate":0.545455,"avgChangeRate":0.002532},{"month":9,"riseRate":0.5,"avgChangeRate":-0.010889},{"month":10,"riseRate":0.5,"avgChangeRate":-0.000757},{"month":11,"riseRate":0.666667,"avgChangeRate":0.022304},{"month":12,"riseRate":0.47619,"avgChangeRate":-0.000548}],"exchange":"NYSE","name":"BME信托","nameEN":"BlackRock Health Sciences Trust"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BME信托(BME)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BME信托(BME)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BME信托,BME,BME信托股票,BME信托股票老虎,BME信托股票老虎国际,BME信托行情,BME信托股票行情,BME信托股价,BME信托股市,BME信托股票价格,BME信托股票交易,BME信托股票购买,BME信托股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BME信托(BME)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BME信托(BME)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}